Vischer acted as legal counsel for Haya Therapeutics, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), on the closing of its CHF 18 million seed round. The financing was led
Tags :Vischer
Oculis has closed an oversubscribed USD 57m Series C financing round. It was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay
Relief Therapeutics Holding and APR Applied Pharma Research have signed a binding term sheet for relief to acquire all outstanding shares of APR. According to the Term Sheet, the APR shareholders will receive from Relief
Drägerwerk AG & Co. KGaA, an international operator in the fields of medical and safety technology, has acquired a majority stake in the Swiss-based start-up medical technology company STIMIT. VISCHER advised Stimit and the
Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers. Vischer advised Unsere Champions on
The VISCHER team led by partner Dr. Adrian Dörig (Corporate Finance - pictured) included Dr. Peter Kühn (Counsel, Corporate / M & A), Flavio Langenegger (Associate, Corporate / M & A), Florian Kambor (Junior Associate, Corporate / M&
The Pestalozzi team included Christian Leuenberger (Lead Partner - Capital Markets, Corporate/M&A - pictured), Severin Roelli (Partner - Corpoarte/M&A), Manu Ferro (Associate - Banking & Finance).
VISCHER advised CITIC on all Swiss law matters. The team was led by Benedict F. Christ (partner, corporate/M&A - pictured) and included Lukas Zuest (counsel, head China Desk, corporate/M&A), Aleksandra Simic (
VISCHER advised MCAM as lead counsel. The team was led by partner Felix W. Egli (Corporate/M&A - pictured) and included partner Christoph Niederer (Tax), managing associate Thomas Steiner-Krizaj (Corporate/M&A) , counsel Peter
The team consists of Christian Wyss (Partner, Corporate / M&A), Sebastian Flückiger (Associate, Corporate / M&A), and Adrian Briner (Associate, Tax).
